Publication & Citation Trends
Publications
0 total
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. OA
Cited by 130
Semantic Scholar
Inactivation of the Complement Lectin Pathway by Candida tropicalis Secreted Aspartyl Protease-1. OA
Cited by 16
Semantic Scholar
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models OA
Cited by 8
Semantic Scholar
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. OA
Cited by 478
Semantic Scholar
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses OA
Cited by 12
Semantic Scholar
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays OA
Cited by 273
Semantic Scholar
Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.
Cited by 12
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(16)
COVID-19 Clinical Research Studies
(14)
COVID-19 epidemiological studies
(2)
Immunotherapy and Immune Responses
(2)
Vaccine Coverage and Hesitancy
(2)
Affiliations
Mercy Medical Center
Public Health England
University of Oxford
De Montfort University